LOS ANGELES, CA / ACCESSWIRE / October 3, 2023 / Immunoglobulin National Society (IgNS) announced today it is partnering with the Accreditation Commission for Health Care (ACHC), an internationally recognized accreditation leader that develops solutions for healthcare providers worldwide. The partnership advances the accreditation of organizations involved in Ig Therapy practice and aims to assist in establishing and maintaining compliance for those who are both ACHC and IgNS members.
“As the only multidisciplinary, standards-setting organization in the field of Ig therapy, IgNS is committed to advancing clinical practice this highly complex field necessitates,” said Luba Sobolevsky, PharmD, IgCP®, President/CEO of IgNS. “The mission of IgNS is to establish and maintain best clinical practice and optimal patient outcomes through national standards, systematic education, professional certification, and comprehensive resources. Our strategic alliance with ACHC provides IgNS members with wide-ranging benefits in access to accreditation services, including education, training, guidance, and preparation. Our partnership with ACHC underscores the value of both our organizations in supporting our members, improving clinical practice, and ultimately, protecting patients’ lives. We are excited to commence this partnership and support the specialized Ig and biologic therapies field. Our collaboration benefits IgNS members, ACHC clients, and our industry as a whole.”
“The benefits of this partnership impact organizations, clinicians, and patients receiving these lifesaving therapies,” said Joseph W. Coyne, ACHC Pharmacy Program Director. “The Immunoglobulin National Society provides comprehensive resources to the Ig therapy clinical community.”
About IgNS
The Immunoglobulin National Society (IgNS) is the only national standards-setting organization dedicated to Ig therapy and biologics fields. IgNS reaches over 35,000 healthcare professionals and over 5,000 patients with the Standards of Practice, specialized education, professional credentialing, and comprehensive resources. The members of IgNS represent leading clinicians, provider organizations, pharmaceutical, biotechnology, and device manufacturers, group purchasing organizations, technology and logistics providers, wholesalers and distributors, advocacy, and trade groups, and more.
Learn more about IgNS at ig-ns.org, email info@ig-ns.org, or call (888)855-4443.
About ACHC
With over 35 years of experience, ACHC has a history of driving success with industry-leading programs. ACHC develops solutions for healthcare providers worldwide and remains committed to delivering a customized, collaborative accreditation experience.
To learn more, visit achc.org, email customerservice@achc.org, or call (855) 937-2242.
Contact Information
Dylan Breton
Director, Marketing Communications
info@ig-ns.org
8888554443
SOURCE: Immunoglobulin National Society
View source version on accesswire.com:
https://www.accesswire.com/786848/the-immunoglobulin-national-society-and-achc-announce-partnership
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…
BELFAST, Northern Ireland , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…